Literature DB >> 29370364

Adherence of Clostridium perfringens spores to human intestinal epithelial Caco-2 cells.

Hideyo Sakanoue1, Takashi Nakano2, Kouichi Sano2, Mayo Yasugi1, Chie Monma3, Masami Miyake1.   

Abstract

Clostridium perfringens is a gram-positive, spore-forming bacillus, and is a causative agent of foodborne infection, antibiotic-associated diarrhoea and sporadic diarrhoea in humans. In cases of antibiotic-associated and sporadic diarrhoea, C. perfringens colonises the intestine, proliferates and causes disease. However, bacterial colonisation of the intestine is not considered necessary in the pathogenesis of foodborne illness, because such pathogenesis can be explained by anchorage-independent production of diarrhoeic toxin by the bacterium in the intestine. In this study, we used an in vitro adherence assay to examine the adherence of C. perfringens spores to human intestinal Caco-2 cells. Adherence of spores from isolates of foodborne illness and nosocomial infection was observed within 15 min, and plateaued 60 min after inoculation. Electron microscopy revealed a tight association of spores with the surface of Caco-2 cells. The adherence of vegetative cells could not be confirmed by the same method, however. These results suggest that C. perfringens spores may adhere to intestinal epithelial cells in vivo, although its biological significance remains to be determined.

Entities:  

Mesh:

Year:  2018        PMID: 29370364     DOI: 10.1093/femsle/fny016

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  1 in total

1.  Focal duodenal necrosis in chickens: attempts to reproduce the disease experimentally and diagnostic considerations.

Authors:  Ana M Villegas; Lisa Stabler; Robert J Moore; Francisco A Uzal; Jake A Lacey; Charles Hofacre; Margie Lee; Naola Ferguson-Noel; Rosetta Barber; Claire-Sophie Rimet; Carmen Jerry; Woo Kyun Kim; Barquiesha Madison; Monique França
Journal:  J Vet Diagn Invest       Date:  2020-01-26       Impact factor: 1.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.